High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection.
Yang JC, Lin CJ, Wang HL, Chen JD, Kao JY, Shun CT, Lu CW, Lin BR, Shieh MJ, Chang MC, Chang YT, Wei SC, Lin LC, Yeh WC, Kuo JS, Tung CC, Leong YL, Wang TH, Wong JM.
Yang JC, et al.
Clin Gastroenterol Hepatol. 2015 May;13(5):895-905.e5. doi: 10.1016/j.cgh.2014.10.036. Epub 2014 Nov 14.
Clin Gastroenterol Hepatol. 2015.
PMID: 25460556
Free PMC article.
Clinical Trial.